FDA veteran Woodcock being considered to lead agency under Biden

14 January 2021 - Joshua Sharfstein, former Obama FDA official, also in running. ...

Read more →

ICER opens nominations for new members of its voting panels

2 December 2020 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other ...

Read more →

Second Trump appointee out at FDA amid credibility concerns

2 September 2020 - A second Trump administration appointee has been ousted at the Food and Drug Administration after the agency’s ...

Read more →

FDA ousts spokeswoman after COVID therapy misstatements

29 August 2020 - Emily Miller joined the agency as chief spokeswoman this month. ...

Read more →

The new Janet: the FDA turns to a quiet problem-solver who brings expertise — and a little controversy

23 June 2020 - Janet Woodcock, one of the FDA’s most powerful regulators, has an almost mythic reputation and an ...

Read more →

FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on COVID-19 vaccine project

22 May 2020 - FDA stalwart Janet Woodcock will temporarily step aside as the director of the agency’s Center for ...

Read more →

Director of U.S. agency key to vaccine development leaves role suddenly amid coronavirus pandemic

21 April 2020 - Rick Bright, one of the nation’s leading vaccine development experts and the director of the Biomedical ...

Read more →

The FDA is in trouble. Here’s how to fix it.

11 January 2020 - Some New Year’s resolutions for the incoming boss. ...

Read more →

Senate confirms Stephen Hahn to head FDA

12 December 2019 - The Food and Drug Administration has been without a permanent commissioner since April, when Dr. Scott Gottlieb ...

Read more →

Dr. Stephen Hahn nominated to be next FDA commissioner

6 November 2019 - The Trump administration on Tuesday formally nominated Dr. Stephen Hahn to be the next commissioner of ...

Read more →

FDA Office of Hematology Oncology Products reorganises, renamed Office of Oncologic Diseases

6 November 2019 - The U.S. FDA’s office responsible for reviewing applications for new and existing cancer therapies has reorganized ...

Read more →

Trump set to nominate Texas cancer doctor to head FDA

25 October 2019 - If confirmed, Stephen Hahn would succeed acting commissioner Norman “Ned” Sharpless. ...

Read more →

Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process

1 October 2019 - President Trump is set to nominate Dr. Stephen Hahn to lead the Food and Drug Administration, ...

Read more →

FDA begins reorganisation phase of modernisation efforts to increase efficiency and further support new drug development

26 September 2019 - Today, the U.S. FDA’s Center for Drug Evaluation and Research (CDER) announced that the reorganization of certain ...

Read more →

Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them

10 September 2019 - Before he interviewed with President Trump last week to become FDA commissioner, Dr. Stephen Hahn had ...

Read more →